CHMX · As filed with the SEC
NEXT-ChemX cash flow statement, by fiscal year
The statement as NEXT-ChemX presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Statement of Cash Flows · USD
| USD | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Dec 31, 2021 |
|---|---|---|---|---|
| OPERATING ACTIVITIES | ||||
| Net income(loss) | (1,814,326) | (2,361,231) | (1,743,799) | (1,784,370) |
| Net loss from continuing operations | — | — | — | (1,784,370) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation and amortization | 155,118 | 5,336 | 5,160 | 352,523 |
| Gain on settlement of debt | — | — | — | (15,955) |
| Other income received in 3rd party stock | — | (203,050) | — | — |
| Unrealized loss on trading securities | — | 36,581 | — | — |
| Unrealized loss on trading securities | 26,395 | — | — | — |
| Consultant commission paid in third party stock | — | 101,525 | — | — |
| Total Costs and Expenses | — | 500,000 | — | — |
| Changes in Operating Assets and Liabilities: | ||||
| Accounts payable and accrued liabilities | 556,074 | 1,394,467 | 824,124 | 743,720 |
| Prepaid expenses | (531,443) | (50,756) | (20,570) | 542 |
| Net cash provided by (used in) operating activities from continuing operations | — | — | — | (703,540) |
| Net Cash from Operating Activities | 75,247 | 32,238 | — | — |
| Net cash provided by (used in) operating activities | (1,532,935) | (544,890) | (935,085) | (703,540) |
| INVESTING ACTIVITIES | ||||
| Purchase of Property and Equipment | — | — | (1,577) | (24,050) |
| Net cash provided by (used in) investing activities from continuing operations | — | — | — | (24,050) |
| Net cash provided by investing activities | — | — | (1,577) | 1,040 |
| FINANCING ACTIVITIES | ||||
| Stock Repurchases (Issuances) | — | 500,000 | — | — |
| Proceeds from Debt Issuance | — | — | — | 672,500 |
| Proceeds from convertible notes payable - related party, net of original issue discounts | — | — | — | 15,000 |
| Proceeds from Debt Issuance | — | — | 60,000 | 5,900 |
| Net cash provided by financing activities from continuing operations | — | — | — | 693,400 |
| Proceeds from Debt Issuance | 20,000 | 465,000 | — | — |
| Proceeds from Debt Issuance | 1,585,004 | — | 1,056,007 | — |
| Net Cash from Financing Activities | — | — | 11,980 | — |
| Repayment of convertible notes payable | — | — | (37,500) | — |
| Net Cash from Financing Activities | — | — | (130,000) | — |
| Repayment of loan payable | — | (20,000) | — | — |
| Repayment of note payable | — | (426,007) | — | — |
| Repayment of related party loans | — | — | (5,900) | — |
| Repayment of equity escrow account | (11,980) | — | — | — |
| Net cash (used in) financing activities | 1,593,024 | 518,993 | 954,587 | 693,400 |
| Net increase (decrease) in cash | 60,089 | (25,897) | 17,925 | (34,190) |
| Cash, beginning of year | 2,458 | 28,355 | 10,429 | 44,619 |
| Cash, end of year | 62,457 | 2,458 | 28,354 | 10,429 |
| SUPPLEMENTAL DISCLOSURES: | ||||
| Cash paid during the period for: | ||||
| Interest Expense | 0 | 37,212 | 14,022 | — |
| Supplemental non-cash investing and financing activities | ||||
| Common stock issued for purchase of intangible asset | — | — | — | 3,500,127 |
| Cancellation of shares | — | — | — | 5,418 |
| Related Party debt forgiveness | — | — | — | 151,137 |
| Common Stock issued on Conversion of 3rd party loan | — | — | 686,505 | — |
| Common stock issued on conversion of related party loan | — | — | 76,677 | — |
| Conversion of loan to convertible note | 174,004 | — | — | — |
| Issuance of Preferred Stocks against Indebtedness | 40 | — | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.